KYT-0353 is primarily utilized in the field of medical research, particularly in the study of neurodegenerative diseases. It has shown potential in modulating specific pathways involved in neuronal protection and repair, making it a candidate for therapeutic development. Researchers are exploring its efficacy in models of conditions such as Alzheimer's and Parkinson's disease, focusing on its ability to reduce neuronal damage and improve cognitive function. Additionally, KYT-0353 is being investigated for its role in enhancing synaptic plasticity, which could aid in recovery from brain injuries. Its application extends to preclinical studies, where it is used to understand the mechanisms of neuroprotection and to identify potential drug targets.